scholarly article | Q13442814 |
P356 | DOI | 10.3181/00379727-135-35031 |
P698 | PubMed publication ID | 4320336 |
P2093 | author name string | L French | |
B B Wentworth | |||
P433 | issue | 2 | |
P304 | page(s) | 253-258 | |
P577 | publication date | 1970-11-01 | |
P1433 | published in | Proceedings of the Society for Experimental Biology and Medicine | Q45038026 |
P1476 | title | Plaque assay of cytomegalovirus strains of human origin | |
P478 | volume | 135 |
Q40710980 | 2,3,7,8-Tetrachlorodibenzo-p-dioxin is a possible activator of human cytomegalovirus replication in a human fibroblast cell line |
Q44214151 | A combination of human cytomegalovirus (HCMV)-specific murine monoclonal antibodies exhibits synergistic antiviral activity in vitro |
Q36826035 | A human cytomegalovirus function inhibits replication of herpes simplex virus |
Q35083082 | A protein-based therapeutic for human cytomegalovirus infection |
Q33978966 | A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates |
Q89685943 | ATeam technology for detecting early signs of viral cytopathic effect |
Q34286411 | Aberrant fetal macrophage/microglial reactions to cytomegalovirus infection. |
Q70099792 | Abortive infection with human cytomegalovirus induces an alteration of growth pattern: morphological changes with cytocidal effect in rabbit kidney epithelial cells. Brief report |
Q45800649 | Activation of herpes simplex virus (HSV) type 1 genome by temperature-sensitive mutants of HSV type 2 |
Q36903371 | Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components |
Q35833368 | Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis. |
Q34420868 | Alteration of host defense mechanisms by murine cytomegalovirus infection |
Q37054374 | Alteration of the growth of cytomegalovirus and herpes simplex virus type 1 by epidermal growth factor, a contaminant of crude human chorionic gonadotropin preparations |
Q38538166 | Analysis of structural polypeptides of purified human cytomegalovirus |
Q33293658 | Antisense transcription in the human cytomegalovirus transcriptome |
Q33883807 | Antiviral actions of flavanoid-derived compounds on dengue virus type-2 |
Q70177961 | Beta interferon production in primed and unprimed cells infected with human cytomegalovirus |
Q24655832 | CD13 (human aminopeptidase N) mediates human cytomegalovirus infection |
Q34126497 | Candidate cytomegalovirus strain for human vaccination |
Q72923259 | Characterization of human cells persistently infected with cytomegalovirus and exposed to a chemical carcinogen |
Q70194409 | Coestablishment of persistent infection and oncogenic transformation of hamster embryo cells by equine cytomegalovirus |
Q41188836 | Comparison of In Vitro Lymphocyte Proliferations Induced by Cytomegalovirus-Infected Human Fibroblasts and Cell-Free Cytomegalovirus |
Q40630201 | Concentration of herpesviruses |
Q36596395 | Construction of a cloned library of the EcoRI fragments from the human cytomegalovirus genome (strain AD169) |
Q53553058 | Cytomegalovirus Replicates in Differentiated But Not in Undifferentiated Human Embryonal Carcinoma Cells |
Q34169756 | Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts |
Q34117745 | Cytomegalovirus infection in a volunteer blood donor population |
Q44676762 | Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression |
Q33558211 | Cytomegalovirus replicates efficiently in human kidney mesangial cells |
Q36553512 | Cytomegalovirus replication in cells pretreated with 5-iodo-2'-deoxyuridine |
Q36500310 | DNA of human cytomegalovirus: size heterogeneity and defectiveness resulting from serial undiluted passage |
Q36647204 | Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection |
Q36599162 | Demonstration of an IgG-Fc receptor in ratcytomegalovirus infected cells |
Q36771127 | Demonstration of immunoglobulin G receptors induced by human cytomegalovirus |
Q35370135 | Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target |
Q72891508 | Detection of human cytomegalovirus-specific igg antibodies by a sensitive solid-phase radioimmunoassay and by a rapid-screening test |
Q36689261 | Differentiation of human embryonal carcinoma cells induces human immunodeficiency virus permissiveness which is stimulated by human cytomegalovirus coinfection |
Q39577917 | Distinct pathways for tumor necrosis factor alpha and ceramides in human cytomegalovirus infection. |
Q34969754 | Effect of Cytosine Arabinoside and 5-Iodo-2′-Deoxyuridine on a Cytomegalovirus Infection in Newborn Mice |
Q70082338 | Effect of DNA polymerase inhibitors on the replication of human cytomegalovirus. Brief report |
Q38889865 | Effects of cytomegalovirus infection in human neural precursor cells depend on their differentiation state. |
Q68998959 | Effects of interferons and interleukin 2 on natural killing of cytomegalovirus-infected fibroblasts |
Q28366318 | Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication |
Q40042640 | Enhancement human cytomegalovirus replication in a human lung fibroblast cell line by interleukin-8. |
Q39733632 | Envelopment of human cytomegalovirus occurs by budding into Golgi-derived vacuole compartments positive for gB, Rab 3, trans-golgi network 46, and mannosidase II. |
Q36355255 | Epstein-Barr virus regulates activation and processing of the third component of complement |
Q43732133 | Equine cytomegalovirus: Cultural characteristics and properties of viral DNA |
Q70199708 | Equine cytomegalovirus: Structural proteins of virions and nucleocapsids |
Q36694813 | Expression of a human cytomegalovirus receptor correlates with infectibility of cells |
Q41501672 | Expression of protein kinase A and protein kinase C during ongoing human cytomegalovirus infection. |
Q39785429 | Flow cytometric analysis of herpes simplex virus type 1 susceptibility to acyclovir, ganciclovir, and foscarnet. |
Q33661417 | Flow cytometric determination of ganciclovir susceptibilities of human cytomegalovirus clinical isolates |
Q40630705 | Growth characteristics of cytomegalovirus in human fibroblasts with demonstration of protein synthesis early in viral replication |
Q36594760 | Herpes simplex virus and human cytomegalovirus replication in WI-38 cells. I. Sequence of viral replication |
Q36518904 | Herpes simplex virus and human cytomegalovirus replication in WI-38 cells. III. Cytochemical localization of lysosomal enzymes in infected cells |
Q44815832 | High expression of human cytomegalovirus (HCMV)-gB protein in cells infected with a vaccinia-gB recombinant: the importance of the gB protein in HCMV immunity |
Q55193404 | High-sensitivity virus and mycoplasma screening test reveals high prevalence of parvovirus B19 infection in human synovial tissues and bone marrow. |
Q28069489 | How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients |
Q41953597 | Human CMV infection induces 5-lipoxygenase expression and leukotriene B4 production in vascular smooth muscle cells |
Q39997511 | Human Cytomegalovirus Inhibits Differentiation of Monocytes into Dendritic Cells with the Consequence of Depressed Immunological Functions |
Q40160894 | Human cytomegalovirus DNA. I. Molecular weight and infectivity |
Q36830676 | Human cytomegalovirus binding to fibroblasts is receptor mediated |
Q42737929 | Human cytomegalovirus downregulates expression of receptors for platelet-derived growth factor by smooth muscle cells |
Q39880441 | Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1- and NF-kappaB-binding sites of the interleukin-8 gene. |
Q36356039 | Human cytomegalovirus induces stage-specific embryonic antigen 1 in differentiating human teratocarcinoma cells and fibroblasts |
Q42531590 | Human cytomegalovirus infection of M1 and M2 macrophages triggers inflammation and autologous T-cell proliferation. |
Q39992541 | Human cytomegalovirus inhibits cytokine-induced macrophage differentiation |
Q35024214 | Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells |
Q39652186 | Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor |
Q72716945 | Human cytomegalovirus persists in cells treated with interferon |
Q40115481 | Human cytomegalovirus productively infects primary differentiated macrophages |
Q34301906 | Human cytomegalovirus protein pp71 disrupts major histocompatibility complex class I cell surface expression |
Q36871678 | Human cytomegalovirus regulates bioactive sphingolipids |
Q36747994 | Human cytomegalovirus secretome contains factors that induce angiogenesis and wound healing |
Q41876583 | Human cytomegalovirus subverts the functions of monocytes, impairing chemokine-mediated migration and leukocyte recruitment. |
Q37355971 | Human cytomegalovirus-induced immunosuppression. Relationship to tumor necrosis factor-dependent release of arachidonic acid and prostaglandin E2 in human monocytes |
Q44636439 | Human cytomegalovirus-specific cytotoxic T cells: their precursor frequency and stage specificity |
Q41906749 | Human cytomegalovirus. Stimulation of [3H] release from [3H]-arachidonic acid prelabelled cells |
Q33928263 | Human cytomegalovirus: demonstration of permissive epithelial cells and nonpermissive fibroblastic cells in a survey of human cell lines |
Q40009723 | Human cytomegalovirus: glycoproteins associated with virions and dense bodies |
Q36919288 | Identification and characterization of the human cytomegalovirus immediate-early region 2 gene that stimulates gene expression from an inducible promoter |
Q47393523 | Improved detection and quantification of mouse cytomegalovirus by real-time PCR |
Q24808870 | In Vitro Anti-Cytomegalovirus Activity of Kampo (Japanese Herbal) Medicine |
Q40156797 | Inactivation of human cytomegalovirus by phytohemagglutinin |
Q44910565 | Induction of chromosome aberrations and mitotic arrest by cytomegalovirus in human cells |
Q50451824 | Induction of cytomegalovirus-infected labyrinthitis in newborn mice by lipopolysaccharide: a model for hearing loss in congenital CMV infection. |
Q36546723 | Induction of murine p30 by superinfecting herpesviruses |
Q40198983 | Infection of human amnion cells with cytomegalovirus |
Q69838347 | Infection of human thymic epithelial cells by human cytomegalovirus and other viruses: effect on secretion of interleukin 1-like activity |
Q45798120 | Infection of laboratory rats with a new cytomegalo-like virus |
Q89977601 | Inhibition of Human Cytomegalovirus Entry into Host Cells Through a Pleiotropic Small Molecule |
Q35789158 | Innate immune responses to cytomegalovirus infection in the developing mouse brain and their evasion by virus-infected neurons |
Q36426770 | Interaction of cytomegalovirus immune complexes with host cells |
Q37376709 | Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines |
Q40087350 | Intranuclear accumulation of subgenomic noninfectious human cytomegalovirus DNA in infected cells in the presence of ganciclovir |
Q36596871 | Isolation of a cytomegalovirus-like agent from wild rats |
Q44057418 | Latent infection of human ovarian teratocarcinoma cells with human cytomegalovirus. Brief report |
Q33908470 | Lymphocyte blastogenesis and interferon production in adult human leukocyte cultures stimulated with cytomegalovirus antigens |
Q72956050 | Lymphoid cell killing by human cytomegalovirus |
Q44806518 | Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. I. Prolonged suppression of in vitro lymphocyte responses against CMV infected fibroblasts related to previous secondary CMV infection. |
Q68666577 | Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet-irradiated human cytomegalovirus |
Q37244991 | Microculture plaque assay for human and simian cytomegaloviruses |
Q33846984 | Mouse embryonic stem cells inhibit murine cytomegalovirus infection through a multi-step process |
Q67236233 | Neutralization and sensitization of cytomegalovirus by IgG antibody, anti-IgG antibody, and complement |
Q36905093 | Organization and expression of the immediate early genes of human cytomegalovirus |
Q33922965 | Patterns of Transcription of Human Cytomegalovirus in Permissively Infected Cells |
Q34424589 | Persistence of cytomegalovirus in human lymphoblasts and peripheral leukocyte cultures |
Q36502186 | Persistence of the cytomegalovirus genome in human cells |
Q37506103 | Physiological State of Human Embryonic Lung Cells Affects Their Response to Human Cytomegalovirus |
Q24654273 | Plaque reduction neutralization test for human cytomegalovirus based upon enhanced uptake of neutral red by virus-infected cells |
Q67915468 | Preservation of natural endothelial cytopathogenicity of cytomegalovirus by propagation in endothelial cells |
Q37255379 | Production and characterization of monoclonal antibodies specific for a glycosylated polypeptide of human cytomegalovirus |
Q36500833 | Production of plasminogen activator by human and hamster cells infected with human cytomegalovirus |
Q52212255 | Prolonged infection of mouse brain neurons with murine cytomegalovirus after pre- and perinatal infection. |
Q42081310 | Protein pUL128 of human cytomegalovirus is necessary for monocyte infection and blocking of migration |
Q39468915 | Quantitation of cytomegalovirus: methodologic aspects and clinical applications. |
Q44184113 | Rabbit kidney cells abortively infected with human cytomegalovirus are arrested in mitotic phase |
Q33696787 | Rapid ganciclovir susceptibility assay using flow cytometry for human cytomegalovirus clinical isolates |
Q40191687 | Rapid quantitation of cytomegalovirus and assay of neutralizing antibody by using monoclonal antibody to the major immediate-early viral protein |
Q72727033 | Rat cytomegalovirus: induction of and sensitivity to interferon |
Q33983181 | Reactivation of herpes simplex virus type 2 from a quiescent state by human cytomegalovirus |
Q34342396 | Reactivation of latent cytomegalovirus infection in mouse brain cells detected after transfer to brain slice cultures |
Q42616123 | Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors |
Q39606146 | Reduced expression of HLA class II molecules and Iinterleukin-10- and transforming growth factor beta1-independent suppression of T-cell proliferation in human cytomegalovirus-infected macrophage cultures |
Q69076609 | Replication of cytomegalovirus in human thymic epithelial cells |
Q36542402 | Replication of human cytomegalovirus DNA: lack of dependence on cell DNA synthesis |
Q40131126 | Replication of human cytomegalovirus in human peripheral blood T cells |
Q36376305 | Repression and activation of the genome of herpes simplex viruses in human cells |
Q40571311 | Rhesus monkey rhadinovirus (RRV): construction of a RRV-GFP recombinant virus and development of assays to assess viral replication |
Q37601559 | Sequence of protein synthesis in cells infected by human cytomegalovirus: early and late virus-induced polypeptides |
Q36556598 | Stimulation of cellular DNA synthesis by human cytomegalovirus |
Q40202314 | Stimulation of host DNA synthesis and induction of early antigens by ultraviolet light irradiated human cytomegalovirus |
Q36911017 | Structural analysis of the major immediate early gene of human cytomegalovirus |
Q34078753 | Susceptibility of lymphoblastoid cells to infection with human cytomegalovirus |
Q52234614 | Susceptibility of mouse embryo to murine cytomegalovirus infection in early and mid-gestation stages. |
Q37506885 | Synthesis of Proteins and Glycoproteins in Cells Infected with Human Cytomegalovirus |
Q37507376 | Temperature-sensitive mutants of human cytomegalovirus |
Q28264539 | Temporal Patterns of Human Cytomegalovirus Transcription: Mapping the Viral RNAs Synthesized at Immediate Early, Early, and Late Times After Infection |
Q35237571 | Temporal regulation of human cytomegalovirus transcription at immediate early and early times after infection |
Q53831437 | The anti-human cytomegalovirus drug tricin inhibits cyclin-dependent kinase 9. |
Q33584744 | The carboxy terminal region of the human cytomegalovirus immediate early 1 (IE1) protein disrupts type II inteferon signaling |
Q43794908 | The cellular immune response to cell-associated and cell-free cytomegalovirus (CMV) antigens after primary CMV-infection in non-immunocompromised hosts: development and maintenance of CMV-latency and its influence on immunocompetence |
Q40291376 | The effects of ultraviolet and ionizing radiation on herpesviruses, SV 40 and adenoviruses in relation to the small-plaque effect |
Q36626536 | The human cytomegalovirus 86-kilodalton immediate-early 2 protein: synthesis as a precursor polypeptide and interaction with a 75-kilodalton protein of probable viral origin |
Q36806546 | The human cytomegalovirus receptor on fibroblasts is a 30-kilodalton membrane protein |
Q40095355 | The role of defective cytomegalovirus particles in the induction of host cell DNA |
Q35834106 | Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection |
Q40113755 | Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages |
Q34073558 | Use of time-saving flow cytometry for rapid determination of resistance of human cytomegalovirus to ganciclovir |
Q70181515 | Viral replication in HeLa/fibroblast hybrid cells infected with human cytomegalovirus |
Search more.